Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Letrozole × 90 days × Clear all

Phase

Status

Recruiting 31 Active not recruiting 31 Not yet recruiting 6 Completed 6 Enrolling by invitation 2 Terminated 1 Suspended 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Cancer Metastatic 1

Interventions

pembrolizumab 34 Nivolumab 12 Carboplatin 10 venetoclax 9 Specimen Handling 9 Biopsy 9 Gemcitabine 8 fludarabine 7 atezolizumab 7 Radiosurgery 7 Pemetrexed 7 Magnetic Resonance Spectroscopy 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Paclitaxel 6 Docetaxel 6 Cyclophosphamide 6 Trastuzumab 5 Interviews as Topic 5 Fulvestrant 5 Drug Therapy 5 tislelizumab 4 binimetinib 4 X-Rays 4 Radiotherapy 4 Radiation 4 Ipilimumab 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04059484 2026-02-24

AMEERA-3

Sanofi

Phase 2 Terminated

367 enrolled 30 charts

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡